CSNK2A1/CK II alpha 抗体 (AA 1-100)
-
- 抗原 See all CSNK2A1/CK II alpha (CSNK2A1) 抗体
- CSNK2A1/CK II alpha (CSNK2A1) (Casein Kinase 2 alpha 1 (CSNK2A1))
-
抗原表位
- AA 1-100
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CSNK2A1/CK II alpha antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Proximity Ligation Assay (PLA)
- 原理
- Mouse monoclonal antibody raised against a partial recombinant CSNK2A1.
- 序列
- MSGPVPSRAR VYTDVNTHRP REYWDYESHV VEWGNQDDYQ LVRKLGRGKY SEVFEAINIT NNEKVVVKIL KPVKKKKIKR EIKILENLRG GPNIITLADI
- 交叉反应
- 人
- 产品特性
- Antibody Reactive Against Recombinant Protein.
- 免疫原
- CSNK2A1 (AAH11668, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- 克隆位点
- 3D9
- 亚型
- IgG2a
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- In 1x PBS, pH 7.4
- 注意事项
- Aliquot to avoid repeated freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation." in: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 3, pp. 381-8, (2011) (PubMed).
: "
-
CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation." in: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 3, pp. 381-8, (2011) (PubMed).
-
- 抗原
- CSNK2A1/CK II alpha (CSNK2A1) (Casein Kinase 2 alpha 1 (CSNK2A1))
- 别名
- CSNK2A1 (CSNK2A1 产品)
- 背景
-
Full Gene Name: casein kinase 2, alpha 1 polypeptide
Synonyms: CK2A1,CKII - 基因ID
- 1457
- 途径
- SARS-CoV-2 Protein Interactome
-